On Nov. 9, 2020, the Fred Hutchinson Cancer Research Center announced the start of volunteer enrollment for a COVID-19 vaccine trial.

The phase 3 study will examine whether AstraZenecaﾒs AZD1222 vaccine can protect against COVID-19 and also prevent infection with SARS-CoV-2, the virus responsible for the COVID-19 disease.